How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Have some old notes in another OneNote but want to merge them into a new notebook related to those notes without copying and pasting the notes in the new notebook. There is a feature in OneNote called ...

We examine how AI is changing the future of work — and how, in many ways, that future is already here. Every tech company you can think of is jumping on the generative AI bandwagon and touting new ...

While shutting down or restarting your PC, you may see a warning message Someone else is still using this PC. Usually, this message appears when there is more than one user account created on a ...

Some of the Capital One offers mentioned below are not currently available. Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. The Petal® 2 "Cash Back, No ...

Modern businesses run on data. Companies regularly capture, store and analyze large amounts of quantitative and qualitative data on consumer behavior, to which they can apply predictive analytics to ...